Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation

Thumbnail
View/ Open

Show full item record

Author
Boykin, Christi; Zhang, G.; Chen, Y-H; Zhang, R-W; Fan, X-E; Yang, W-M; Lu, Q.
URI
http://hdl.handle.net/10342/5298
Date
2011-03
Citation:
APA:
Boykin, Christi, & Zhang, G., & Chen, Y-H, & Zhang, R-W, & Fan, X-E, & Yang, W-M, & Lu, Q.. (March 2011). Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British Journal of Cancer, (104:5), p.781-789. Retrieved from http://hdl.handle.net/10342/5298

Display/Hide MLA, Chicago and APA citation formats.

MLA:
Boykin, Christi, and Zhang, G., and Chen, Y-H, and Zhang, R-W, and Fan, X-E, and Yang, W-M, and Lu, Q.. "Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation". British Journal of Cancer. 104:5. (781-789.), March 2011. October 27, 2020. http://hdl.handle.net/10342/5298.
Chicago:
Boykin, Christi and Zhang, G. and Chen, Y-H and Zhang, R-W and Fan, X-E and Yang, W-M and Lu, Q., "Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation," British Journal of Cancer 104, no. 5 (March 2011), http://hdl.handle.net/10342/5298 (accessed October 27, 2020).
AMA:
Boykin, Christi, Zhang, G., Chen, Y-H, Zhang, R-W, Fan, X-E, Yang, W-M, Lu, Q.. Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. British Journal of Cancer. March 2011; 104(5) 781-789. http://hdl.handle.net/10342/5298. Accessed October 27, 2020.
Collections